Surgical treatment of drug-resistant epilepsy due to mesial temporal sclerosis. Etiology and significance.
about
Kainic acid-induced recurrent mossy fiber innervation of dentate gyrus inhibitory interneurons: possible anatomical substrate of granule cell hyper-inhibition in chronically epileptic ratsClassic hippocampal sclerosis and hippocampal-onset epilepsy produced by a single “cryptic” episode of focal hippocampal excitation in awake ratsLateralization of mesial temporal lobe epilepsy with chronic ambulatory electrocorticographyRelationships between neuropathology and cognitive functioning in temporal lobectomy patients.Temporal lobe epilepsy: origin and significance of simple and complex auras.Amygdalar sclerosis: preoperative indicators and outcome after temporal lobectomy.Mesial temporal sclerosis: pathogenesis, diagnosis, and management.Distinct increased metabotropic glutamate receptor type 5 (mGluR5) in temporal lobe epilepsy with and without hippocampal sclerosis.Aberrations of the sense of smell in head injury and cerebral tumours.Childhood epilepsy in relation to mental handicap and behavioural disorders.Treatment of febrile convulsionsDiverse perspectives on developments in epilepsy surgeryBehaviour changes following temporal lobectomy, with special reference to psychosis.Bilateral reductions in hippocampal volume in adults with epilepsy and a history of febrile seizuresPredictors of prognosis in patients with temporal lobe epilepsy after anterior temporal lobectomy.Role of HHV-6B Infection in Mesial Temporal Lobe EpilepsyRole of oxidative stress in refractory epilepsy: evidence in patients and experimental models.Radiological abnormalities in temporal lobe epilepsy with clinicopathological correlations.The role of interleukin-1beta in febrile seizures.Epilepsy surgery: historical highlights 1909-2009.Disease modification in epilepsy: from animal models to clinical applications.Neuropathological findings following temporal lobectomy related to surface and deep EEG patterns.Clinical neuropathology of the epilepsies in the 100 years of the ILAE (1909-2009).Genetic and related aetiological factors in temporal lobe epilepsy. A review.Hippocampal neuron loss in epilepsy and after experimental seizures.Hippocampal resections and the use of human tissue in defining temporal lobe epilepsy syndromes.The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy.Biological mechanisms influencing the outcome of seizures in response to fever.In vitro quantitative autoradiography of [3H]-L-deprenyl and [3H]-PK 11195 binding sites in human epileptic hippocampus.Management of psychomotor (temporal lobe) seizures."Cerebellar pacemakers".Chemoconvulsant model of chronic spontaneous seizures.Subregional pathology of the amygdala complex and entorhinal region in surgical specimens from patients with pharmacoresistant temporal lobe epilepsy.[Does semi-quantitative analysis of FDG-PET have any additional value in the diagnosis of mesial temporal sclerosis?]Temporal lobe epilepsy after prolonged febrile convulsions: excellent outcome after surgical treatment.The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy.Major advances in epilepsy in the last century: a personal perspective.Alexander Falconer Sr Seamen's missionary in New Zealand, son Alexander Falconer medical superintendent for mentally ill, grandson Murray Falconer neurosurgeon.Predictive factors for success in surgical treatment for partial epilepsy: a multivariate analysis.Surgical treatment for partial epilepsy among Norwegian adults.
P2860
Q28289328-B9F31175-7D0A-4F5E-BB39-005271E4DAE7Q29037057-C048C267-46DE-4B03-B23A-C87EB58CEE72Q30299915-008E51F0-8FAF-457D-832E-0AACB90663D1Q33627204-487B6DD7-7985-4D55-A6B1-6C0E284ED865Q33628564-917361F5-E08D-4B2A-97A7-B5A40A2BFD25Q33733116-E751786E-5B63-44AD-A6A4-7DAF90FA2768Q34134208-155A631F-2DFE-4C39-8B76-251487C220DCQ34193234-31451EC6-18FE-4AB4-95A0-0BF12093354EQ34523384-3645B193-DAE6-4E5F-AC00-5B1878AE902CQ34540188-5B786163-60E8-4AD1-99FE-22913834E383Q35144897-3ADCD1A0-7F0E-4D66-BC22-C63E6C4E4E27Q35586894-8A886A8C-5D82-4F61-A724-C8718895B8FCQ35894729-845E79DF-9B76-4937-BFF3-7FC858E7864BQ36317270-1B481307-7A20-440E-9725-D13E98430278Q36334726-EFF83F35-9016-40E5-A859-2DDC9B768135Q36561882-F93835F6-0F45-4B2F-9FC5-94C450334F13Q36590070-1D2ACDD4-3971-4AA1-9AEE-D9CEB8807268Q37033573-BD03E83B-66C1-4AE6-9E91-DAABE909FAC2Q37235731-5CC4910B-D0E5-4EE3-85C7-584DEB803401Q37418175-CD452F53-95F8-4862-814E-053BBB388C6CQ38450069-74B1D86F-081A-44DF-AF48-865A72CE3B3BQ39566328-8122009D-F5EA-434F-861B-16D22A9D025BQ39992270-25A6B1C0-2469-4F1D-8E1D-3CACF924B90BQ40024886-46865F0F-698E-4B87-90D3-C00C0980599FQ40252750-DD552D19-A658-40C8-9FB3-08A92BB7F6BAQ40583155-2D3344AA-AB26-4914-8B7A-46F431BA8DE2Q40766081-390BA4F2-7F16-4DF9-B376-E45EA9AB9285Q40927089-7DDF820C-9A7B-4AED-9D21-7C732CA8E288Q41114505-429F516F-21BA-45A1-9047-3EA40F0960DFQ41674049-DF01E9F1-CF13-42C1-A99A-AB44FADBF27CQ41889677-F1BB7912-4EE4-4918-82D2-16F0A862D954Q42168255-75FA31C2-14DB-4998-8520-E1AD33112CFAQ42496018-0C42BDD3-1743-4674-BB8E-1B5D255DD6DBQ43815979-6BBD750A-7805-452D-8148-44DB2AC963DBQ44498523-CD1DDAD5-F143-4918-ADED-822B033126D5Q44667891-2D42B26C-7371-4506-96E7-AEF86FEDEEF6Q47608048-68BEFDA5-2442-4B83-B4B4-8E5057E4793DQ48037339-8D8F0D23-65D8-4C37-B756-EB84F44170B8Q48132588-CCAFA616-CD3A-4420-8115-9A39057785ADQ48132606-46518176-C4C9-4193-8085-1DE5D97783DE
P2860
Surgical treatment of drug-resistant epilepsy due to mesial temporal sclerosis. Etiology and significance.
description
1968 nî lūn-bûn
@nan
1968年の論文
@ja
1968年学术文章
@wuu
1968年学术文章
@zh
1968年学术文章
@zh-cn
1968年学术文章
@zh-hans
1968年学术文章
@zh-my
1968年学术文章
@zh-sg
1968年學術文章
@yue
1968年學術文章
@zh-hant
name
Surgical treatment of drug-res ...... is. Etiology and significance.
@en
Surgical treatment of drug-res ...... is. Etiology and significance.
@nl
type
label
Surgical treatment of drug-res ...... is. Etiology and significance.
@en
Surgical treatment of drug-res ...... is. Etiology and significance.
@nl
prefLabel
Surgical treatment of drug-res ...... is. Etiology and significance.
@en
Surgical treatment of drug-res ...... is. Etiology and significance.
@nl
P1433
P1476
Surgical treatment of drug-res ...... is. Etiology and significance.
@en
P2093
Falconer MA
P304
P356
10.1001/ARCHNEUR.1968.00480040019001
P577
1968-10-01T00:00:00Z